Connetics Corporation Company Profile
Connetics Corporation is focused on the acquisition, development and commercialization of marketed and late-stageproducts. The Company's product and commercial focus is initially targeted at rheumatology and dermatology, two specialty medical markets. These commercially attractive markets have large patient populations yet relatively small physician
treating groups. U.S. dermatologists and rheumatologists write prescriptions each year exceeding $5.0 billion. The Company's goal is to leverage these markets by commercializing novel products to meet currently unmet medical needs
and employing focused and highly trained sales staff. Connetics currently markets Ridaura(R) (auranofin), a treatment for rheumatoid arthritis, and ACTIMMUNE(R) (interferon gamma-1b), a treatment for chronic granulomatous disease (beginning January 1999). On March 1, 1999 Connetics received clearance from the FDA to begin marketing Luxiq(TM) (betamethasone valerate) Foam, 0.12%, a product to treat corticosteroid-responsive scalp dermatoses. Connetics has several other products in development: ConXn(R) (recombinant human relaxin H2) ("relaxin"), targeting scleroderma, organ fibrosis, and infertility; and OLUX(TM) (clobetasol propionate) Foam, 0.05%, a novel formulation for the treatment of severe scalp dermatoses; and interferon gamma (through its wholly-owned subsidiary, InterMune Pharmaceuticals, Inc.) for the treatment of certain congenital, infectious and other diseases.
3290 West Bayshore Road
United States of America
Phone: 650 843 2800
Fax: 650 843 2899
GREENSBORO, N.C., July 9, 2012 /PRNewswire/ -- Merz, Inc. (US affiliate of Merz Pharma Group) today announced that Katrina Church has been promoted to vice president, chief compliance officer, ef...
Drugs and Medications
Connetics Corporation is focused on the acquisition, development and commercialization of marketed and late-stageproducts. The Company's product and commercial focus is initially targeted at rheumatol...
More Information about "Connetics Corporation" on BioPortfolio
We have published hundreds of Connetics Corporation news stories on BioPortfolio along with dozens of Connetics Corporation Clinical Trials and PubMed Articles about Connetics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Connetics Corporation Companies in our database. You can also find out about relevant Connetics Corporation Drugs and Medications on this site too.